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Abstract
Research in obesity and metabolic disorders that involve intestinal microbiota demands reliable
methods for the precise measurement of the short-chain fatty acids (SCFAs) and branched-chain
amino acids (BCAAs) concentration. Here, we report a rapid method of simultaneously
determining SCFAs and BCAAs in biological samples using propyl chloroformate (PCF)
derivatization followed by gas chromatography mass spectrometry (GC-MS) analysis. A one-step
derivatization using 100 µL of PCF in a reaction system of water, propanol, and pyridine (v/v/v =
8:3:2) at pH 8 provided the optimal derivatization efficiency. The best extraction efficiency of the
derivatized products was achieved by a two-step extraction with hexane. The method exhibited
good derivatization efficiency and recovery for a wide range of concentrations with a low limit of
detection for each compound. The relative standard deviations (RSDs) of all targeted compounds
showed good intra- and inter-day (within 7 days) precision (< 10%), and good stability (< 20%)
within 4 days at room temperature (23–25 °C), or 7 days when stored at −20 °C. We applied our
method to measure SCFA and BCAA levels in fecal samples from rats administrated with
different diet. Both univariate and multivariate statistics analysis of the concentrations of these
target metabolites could differentiate three groups with ethanol intervention and different oils in
diet. This method was also successfully employed to determine SCFA and BCAA in the feces,
plasma and urine from normal humans, providing important baseline information of the
concentrations of these metabolites. This novel metabolic profile study has great potential for
translational research.
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1 Introduction
The measurement of short-chain fatty acids (SCFAs) and branched-chain amino acids
(BCAAs) (i.e., valine, leucine, and isoleucine) in biological samples receives considerable
attention because of the important role SCFAs and BCAAs play in physiological and
pathological processes (Hijova et al. 2007; Kawaguchi et al. 2011; Miller 2004; Newgard et
al. 2009). SCFAs, also known as “the volatile fatty acids,” contain 2–7 carbon atoms.
Straight-chain SCFAs are mainly produced by microbial fermentation of unabsorbed dietary
carbohydrates in the gut (Cummings 1981) and branched-chain SCFAs such as isobutyric
acid, 2-methylbutyric acid, and isovaleric acid are derived from the catabolism of BCAAs
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(Macfarlane et al. 2003). SCFAs influence the gut microbiota by stimulating bifidobacteria
growth while inhibiting gram-negative facultative and anaerobic bacteria (Andoh et al.
2003), thereby providing important information regarding the bacterial activity in the
intestinal tract. SCFAs also act as nutrients for the colonic epithelium, regulate the colonic
and intracellular environment (Wong et al. 2006), and modulate cell proliferation and gene
expression (Blottiere et al. 2003; Sanderson 2004). Recent studies suggest that SCFAs have
a protective effect against gastrointestinal disorders, colon carcinogenesis, and
cardiovascular disease (Augenlicht et al. 2002; Kles et al. 2006; Wong et al. 2006).
BCAAs are essential nutrients obtained from food, as they cannot be synthesized de novo by
mammals. BCAAs have the unique quality of being poorly metabolized during their first
pass through the liver, which allows them to act as a signal to the brain and the periphery
organs of the amino acid content of our diet (Herman et al.). BCAAs have been clinically
used as nutrition supplements for patients with liver disease or cancer (Holecek ; Muto et al.
2006), because BCAA oxidation provides energy for muscles and other organs. Emerging
evidence indicates that SCFAs and BCAAs are associated with metabolic diseases such as
obesity and diabetes (Vonk et al. 2011; Wang et al. 2011). In fact, SCFAs stimulate leptin
expression and inhibit lipolysis in adipocytes through G-coupled protein receptors, and
activate AMPK, which acts as a major cellular fuel gauge and a master regulator of
metabolic homeostasis (Samuel et al. 2008). Similarly, BCAAs function as potential
regulators of leptin production, glucose homeostasis, cell signaling, and adiposity; abnormal
BCAA levels could be a signal for diabetes prediction (Newgard et al. 2009; Wang et al.
2011). Both SCFAs and BCAAs also play important roles in the nervous system as
transmitters of neural signals (Fernstrom 2005; Jouvet et al. 2000; Kotani et al. 2009; Soret
et al.).
Although a handful of studies investigated the correlation of SCFAs and BCAAs with
pathophysiological states, none were able to measure SCFAs and BCAAs simultaneously in
biological samples. For example, previous studies employed various techniques, such as
direct infusion into capillary electrophoresis (CE) (Arellano et al. 2000; Barbas et al. 1998;
Poinsot et al. 2012), high performance liquid chromatography (HPLC) (Agrafiotou et al.
2009; Albert et al. 1997; Kotani et al. 2009; Stein et al. 1992), or gas chromatography (GC)
(Bachmann et al. 1979; Zhao et al. 2006). However, these methods have disadvantages of
low sensitivity for SCFAs or BCAAs determination in complex biological matrix. Chemical
derivatization (Heinrikson et al. 1984; Miwa et al. 1985; Miwa et al. 1987; Schiffels et al.
2011) and solid phase extraction (Horspool et al. 1991; Wang et al. 2010) prior to HPLC
analysis were also used, which are time-consuming. Headspace extraction techniques in GC
analysis, including purge-and-trap (Mills et al. 1999) or headspace solid-phase
microextraction (HS-SPME) (Bianchi et al. 2011; Mills et al. 1999; Perez Olivero et al.
2011) were used for SCFAs analysis, however, these methods are unsuitable for BCAAs
determination. To date, no method focusing on simultaneous measurement of SCFAs and
BCAAs in complex biological samples has been reported. To develop the ideal method for
this purpose, we used the chloroformate derivatization route invented by Dr. Petr Husek
(Husek 1998), which has many advantages, such as the short reaction time (< 1 min) at room
temperature and the ability to perform the derivatization in aqueous media. Alkyl
chloroformates, favorable reagents for treating amino and fatty acids prior to gas
chromatography have been applied in metabolomic studies (Qiu et al. 2007; Tao et al. 2008).
Dr. Husek has described the use of ethyl chloroformate for plasma amino and organic acids
analysis (Husek 1995) and a commercially successful reagent kit has been developed
recently (Badawy et al. 2008). BCAAs can be accurately measured by these methods,
however, without report the SCFAs were detected. Hence, a comprehensive investigation in
chloroformate derivatization of SCFAs and BCAAs for biological samples is required.
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In our pilot studies, alkyl chloroformates with different lengths of alkyl groups, including
methyl-, ethyl-, propyl-, butyl-, and isobutyl-chloroformate, were compared. Methyl- and
ethyl-chloroformates yielded satisfactory derivatization efficiency, but acetic acid
derivatives were not separated from the solvent peak and so cannot be measured precisely.
Butyl- and isobutyl-chloroformates yielded suboptimal derivatization efficiency. Propyl-
chloroformate (PCF) demonstrated a broad coverage of targeted compounds with
satisfactory derivatization efficiency, and was, therefore, selected as the derivatization
reagent for our study.
We describe here a rapid and quantitative protocol for the simultaneous measurement of
SCFA and BCAA levels in various biological matrices using propyl chloroformate
derivatiztion procedures and GC-MS analysis.
2 Materials and methods
2.1 Chemicals and reagents
Certified ACS grade sodium hydroxide, sodium carbonate, and anhydrous sodium sulfate
were obtained from JT Baker Co. (Phillipsburg, NJ). HPLC grade propanol (PrOH),
pyridine (Py), PCF, and hexane, SCFA and BCAA standards, and propyl derivatives (propyl
acetate, propyl propanoate, propyl isobutyrate, propyl butyrate, propyl isopentanoate, and
propyl hexanoate) were purchased from Sigma-Aldrich (St. Louis, MO). Standard
compounds were prepared in ultrapure water (Milli-Q system, Millipore, Billerica, MA) and
propyl derivatives that were used to evaluate the derivatization efficiency were prepared in
hexane. Stable isotopes (acetic acid-d4, propionic acid-d2, 2-methylbutyric acid-d3, butyric
acid-d2, valeric acid-d9, caproic acid-d3, heptanoic acid-d7, valine-d8, and leucine-d10)
were obtained from CDN Isotopes (Pointe-Claire, Quebec, Canada) for method recovery
evaluation. Caproic acid-d3 was used as an internal standard (IS) for final adjustment on
quantity of each compound present in the biological samples.
2.2 Sample preparation
For feces samples, the extraction procedures were performed at 4 °C to protect the volatile
SCFAs. A total of 1000 µL of 0.005 M aqueous NaOH containing IS (5 µg mL−1 caproic
acid-d3) was added to feces samples (50–150 mg), and the sample was homogenized for 10
min and centrifuged at 13,200 g at 4 °C for 20 min. A 500-µL aliquot of supernatant fecal
water was transferred into a 10 mL Corning disposable glass centrifuge tube, and 300 µL of
water was added to this aliquot. For urine and plasma samples, 300 µL of each sample and
500 µL of 0.005 M aqueous NaOH containing IS (5 µg mL−1 caproic acid-d3) were mixed in
a 10-mL glass centrifuge tube.
An aliquot of 500-µL PrOH/Py mixture solvent (3:2, v/v) and 100 µL of PCF were
subsequently added to the glass tube and were vortexed briefly. Then, the derivatization
reaction proceeded under ultrasonication for 1 min. After derivatization, the derivatives were
extracted by a two-step extraction with hexane. An aliquot of 300-µL hexane was added to
the reaction mixture and the sample was vortexed for 1 min followed by centrifugation at
2,000 g for 5 min. An aliquot of 300-µL derivative extraction (upper hexane layer) was
transferred to a sampling vial. The extraction procedure was then repeated by adding 200 µL
of hexane instead of 300 µL hexane to the reaction mixture. Another 200-µL aliquot of
derivative extraction was transferred to the sampling vial with the first extraction. An aliquot
of 10-µL n-alkane series was added, serving as the retention index and quality control.
Anhydrous sodium sulfate (~10 mg) was added to remove traces of water from hexane. The
resultant mixture was briefly vortexed prior to GC-MS analysis.
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Analysis was performed using an Agilent 7890A gas chromatography system coupled to an
Agilent 5975C inert XL EI/CI mass spectrometric detector (MSD, Agilent Technologies,
Santa Clara, CA). Derivatives were separated using an HP-5ms capillary column coated
with 5% phenyl-95% methylpolysiloxane (30 m × 250 µm i.d., 0.25 µm film thickness,
Agilent J & W Scientific, Folsom, CA). One microliter of derivatives was injected in split
mode with a ratio of 10:1, and the solvent delay time was set to 2.2 min. The initial oven
temperature was held at 50°C for 2 min, ramped to 70 °C at a rate of 10 °C min−1, to 85 °C
at a rate of 3 °C min−1, to 110 °C at a rate of 5 °C min−1, to 290 °C at a rate of 30 °C min−1,
and finally held at 290 °C for 8 min. Helium was used as a carrier gas at a constant flow rate
of 1 mL min−1 through the column. The temperatures of the front inlet, transfer line, and
electron impact (EI) ion source were set at 260, 290, and 230 °C, respectively. The electron
energy was −70 eV, and the mass spectral data was collected in a full scan mode (m/z 30–
600).
2.4 Data processing
To align multiple chromatograms, LECO’s ChromaTOF v4.32 software (Leco Corp., St.
Joseph, MO) was applied. Raw GC-MS data files were converted to NetCDF files using the
Agilent’s MSD Chemstation Data Analysis Application. All of the NetCDF data files were
then imported to ChromaTOF and subject to the following processing including baseline
correction, smoothing, noise reduction, deconvolution, library searching, and area
calculation. Compound identification was performed by comparing both MS spectra and
retention times with those of standard compounds. The peak area of each derivatized SCFA
or BCAA was calculated using the unique mass selected by ChromaTOF. Subsequently, the
“Statistical Compare” function in ChromaTOF software was utilized for the alignment to
generate a data table with all the compound information from different chromatograms.
Statistical Compare utilized a mass spectral match criterion of 70% when aligning the
multidimensional peak data. The data table was exported as a .csv file that included sample
names, compounds, retention time (RT), quantification mass, and peak area. The
quantification mass for each peak in the data set was selected from the unique mass that was
most common in all matching peaks within the retention time window.
3 Results and discussion
3.1 Derivatization optimization
In order to develop an ideal derivatization method based on the reaction of PCF
derivatization (Fig. 1), we tested several different parameters: (1) the volume and ratio of
water, PrOH, Py, and the pH of the derivatization system, (2) one-step vs. two-step
derivatization, and (3) various solvents and procedures for the extraction of propyl ester
derivatives. Pooled sample extracts were used to avoid sample variations. Triplicate samples
for each method were prepared to ensure reproducibility. Average intensities of each
compound were compared across different methods. Feces samples were used for method
development and validation. The method was then tailored to plasma and urine samples.
Sample weight or volume and sample extraction optimization are provided in
Supplementary Information, and supplementary Fig. 1.
3.1.1 Derivatization solvent system—Water, PrOH, and Py are three essential
derivatization solvents, participating in the PCF-triggered derivatization reaction (Husek
1998; Qiu et al. 2007). The optimal volumes of three derivatization solvents were
determined to be 300 µL of PrOH, 200 µL of Py, and 800 µL of water, based on the
following two experiments:
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First, we applied an orthogonal design method with three factors and four levels (Table 1a).
Nine SCFA and three BCAA peaks were identified and used for method evaluation. The
influence of derivatization conditions on the detected signals of SCFAs and BCAAs were
first summarized in Fig. 2. A multivariate statistical method, partial least squares (PLS)
regression, (Fig. 2) presents the correlation between the volume of derivatization solvents
and the intensities of detected compounds (Pan et al. 2010). A two-component PLS model
was generated with the 12 resolved peak areas (X matrix, where each peak area is one X-
variable) of the 48 analyses (triplicates of 16 methods) and the designed parameters (Y
matrix, the amounts of the three derivatization solvents) with R2X, R2Y, and Q2 parameters
of 0.839, 0.342, and 0.293, respectively. The PLS bi-plot shown in Fig. 2 is the combination
of a two-component PLS model loadings plot and scores plot. The PLS loadings plot shows
how the resolved peak areas correlate to the solvent compositions and determines the
distribution of experimental analyses shown on the PLS scores plot. Fig. 2 shows that the
first PLS component is mainly dominated by Py (positively) and water (negatively), and the
second PLS component correlates mainly with PrOH (positively). The samples represented
in the first and fourth quadrants appear to have the most negative correlation with the
compounds. These samples represent all the methods using 50 µL of Py or with the ratio of
water/PrOH larger than 10. These results clearly demonstrate that Py, acting as a catalyst, is
beneficial to the derivatization. The results also indicate that the ratio of water to PrOH
volume should be restricted. Although PLS result shows different responses of these
compounds to different solvent system, the optimal method was selected as a compromise
among these responses, and further investigations were carried out.
To obtain an optimal derivatization method, a second investigation was performed based on
the results above. The second experiment (Table 1b) was conducted to determine the
volumes of water, PrOH and Py. Fig. 3 shows the results of total normalized intensities of
the metabolites, in which the intensity of each detected metabolite was normalized to the
average intensity of that metabolite across all six experiments. These results indicate that Py
does not increase derivatization efficiency when the volume of Py equals or is greater than
the volume of PrOH. As a result, we concluded that 300 µL of PrOH, 200 µL of Py, and 800
µL of water is the optimal condition for derivatization.
We observed that the derivatization with varying volumes of water and PrOH had a dramatic
influence on the derivative extraction procedure. Importantly, increasing the ratio of PrOH
to water raised the volume of the resulting hexane layer, resulting in lower final
concentrations of derivatives. To eliminate this dilution, water, PrOH, and Py, were
supplemented up to a constant volume after the derivatization and before extraction steps.
The optimal pH was determined to be 8.0 with aqueous NaOH solution adjustment. The
results of derivatization at different pH levels were compared by evaluating the total
normalized intensities of the compounds as described in the section 3.1.1. The reaction
system achieved optimal derivatization efficiency in a weak base environment at pH 8.0.
3.1.2 Derivatization procedures—One-step and two-step derivatization procedures
were compared, both of which have been applied in previous alkyl chloroformate
derivatization methods (Husek 1995; Qiu et al. 2007). Five different procedures were
conducted, including two one-step derivatizations (method a and b) and three two-step
derivatizations (method c, d, and e). For one-step derivatizations, 50 µL (method a) or 100
µL (method b) of PCF was added to the reaction mixture, followed by a vortex for 10 s and
ultrasonication for 1 min. A 500-µL aliquot of hexane was then added for derivative
extraction. For the two-step derivatizations, each 50 µL aliquot of PCF was added to the
reaction mixture at two consecutive times, followed by vortexing and ultrasonication after
each derivatization step. The three different procedures were investigated to determine the
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pH adjustment and the derivative extraction procedure. In method c, hexane was added
between the two derivatization steps. In method d, hexane was also added between the two
steps, followed by the addition of 30 µL saturated aqueous NaOH to adjust the pH to 9–10
as previously reported (Qiu et al. 2007). In method e, only 30 µL of saturated aqueous
NaOH was added between the two steps, and hexane was added after the two derivatization
steps. The results (supplementary Fig. 2) show the total normalized intensities of the
metabolites, in which the intensity of each detected metabolite was normalized to the
average intensity of that metabolite across all five methods. The intensity from the one-step
derivatization using 100 µL of PCF (method b) was higher than two that obtained from
methods c and d, and about 5% lower than the one obtained by method e. Since one-step
derivatization was markedly simple and its derivatization efficiency was acceptable, we
selected method b (100 µL of PCF) for derivatization.
3.1.3 Derivative extraction solvent—Liquid-liquid extraction method was applied to
extract derivatives from the reaction system. The aim of this step was not only to switch the
sample solvent from aqueous to non-aqueous, but also to reduce the matrix effect and
concentrate the analytes. Hexane was selected in our study. Compared with chloroform used
in other reports (Husek 1995), hexane in the upper layer facilitates solvent removal and
transferring, improving sample-handling efficiency and enabling large-scale automated
liquid handling of clinical biological samples (Tao et al. 2008; Zheng et al. 2012). The
volume of 500 µL was determined based on the results of volume evaluation. Extraction
efficiency was then evaluated by carefully removing the hexane layer completely, and then
adding 250 µL of hexane to repeat the extraction procedures, in order to assess the amount
of the derivatives that was not extracted in the first extraction. Our results indicate that the
derivatization efficiency of most compounds was about 90% (supplementary Table 1). We
aimed then to develop a two-step extraction procedure to improve this extraction efficiency.
First, 300 µL of hexane was added to reaction system. After 300 µL of the hexane layer was
transferred to a sampling vial, another 200 µL of hexane was added to the reaction system. A
second 200-µL hexane layer was transferred and combined with the first extraction. The
results in supplementary Table 1 show that peak intensities were significantly increased with
this method. More than half of the compounds were completely extracted and the extraction
efficiency of propyl esters of acetic acid, propionic acid, isobutyric acid, butyric acid,
leucine, and isoleucine improved to over 95% efficiency. However, a much lower
concentration of SCFAs was observed in biofluids than in fecal samples, including some
that were lower than the limit of detection (LOD) in our analytical method. Therefore, the
total volume of hexane used in the method should be adjusted to 300 µL to prevent the
dilution of analytes for GC-MS analysis.
3.2 Method validation
Method validation was performed for the quantitative analysis of the SCFAs and BCAAs. A
stock standard mixture was prepared containing 14 SCFAs and 3 BCAAs (Table 2) at a
concentration of 1 mg mL−1 for each standard. The stock solution was further diluted to a
series of concentrations, ranging from 500 to 0.001 µg mL−1. The calibration curve was
constructed by plotting the peak-area ratio of each standard to IS versus concentration. LOD
was obtained accordingly (Table 2).
Intra- and inter-day precision studies were performed using a standard mixture of all the
standards at a concentration comparable to the measured quantities in the biological
samples. Intra-day precision was determined by successive replicate measurements (n = 6)
of the analytes. Inter-day precision was determined by analyzing the samples on four
different days (days 1, 2, 4, and 7). The results in Table 2 exhibited excellent intra-day and
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inter-day precision for most of the compounds with the RSDs below 6% and 9%,
respectively.
Stability studies for the derivatized analytes were performed using biological sample matrix
under three different storage conditions, i.e., room temperature (23–25 °C), −20 °C, and a
12-h room temperature/12 h −20 °C cycle on days 1, 2, 4, and 7. Prepared samples were
separated into four aliquots and stored prior to analysis. Caproic acid, heptanoic acid, and
BCAAs showed good stability within seven days under all three storage conditions
(supplementary Fig. 4). The rest of compounds showed good stability within seven days at
−20 °C, and within four days under the other two conditions.
To determine the derivatization efficiency, standard mixtures were prepared in three
different concentrations and processed using our method. In parallel, blank pure water
instead of standard mixtures was treated with the same procedures, except the derivative
extraction step. Instead of pure hexane, hexane dissolved with commercial available propyl
esters was added. Moles of propyl esters and standards in the standard mixtures were equal
between the parallel samples, so that the peak areas of the added propyl esters could be used
as a benchmark, assuming 100% derivatization efficiency. Derivatization efficiency
(supplementary Table 3) showed satisfactory results for most SCFAs and BCAAs ranging
from 90.06 to 116.34%.
For recovery studies, biological samples were spiked with three levels of analyte isotopes
(low, medium, and high). The medium concentration level was consistent with the analyte
concentration in biological samples, and the low and high levels were 50% and 200% of the
medium level, respectively. The recovery was calculated according to the ratio of the
measured concentration of the analyte isotope versus the spiked isotope concentration. All
isotopes exhibited high recovery rates, ranging from 84.11 to 118.79% (supplementary
Table 3).
3.3 Method application - SCFA and BCAA profiling
To demonstrate the utility of our procedure, this developed method was used to analyze
complex biological samples, including feces, plasma, and urine from animal and human
subjects. One application aimed to differentiate the concentrations of SCFAs and BCAAs in
feces of Sprague-Dawley male rats (16–18 weeks) from three different feeding groups (n = 8
in each group): 1) a “corn oil group” that ingested 35% corn oil in their feed, 2) a “corn oil/
ethanol” group that ingested feed containing 35% corn oil and 7% ethanol, and 3) a
“medium chain fatty acid (MCFAs)/ethanol” group that ingested feed containing 35%
MCFAs and 7% ethanol. Feces were collected after a 15-week dietary intervention. In
another experiment, feces, urine and plasma samples were collected from 15 healthy female
volunteers, who had maintained control diets for ten days to minimize the dietary-induced
metabolism variations. In both rat and human feces samples, 12 metabolites including 9
SCFAs and 3 BCAAs were identified and quantified, while in plasma and urine samples,
two of these SCFAs, namely 2-methylbutyric and isovaleric acid, were not detectable
(Tables 3). The concentrations of three SCFAs, namely acetic, propanoic, and butyric acid,
were predominant in feces samples. In animal experiments, there was an apparent metabolic
discrimination between the two groups administered with ethanol and the group fed corn oil
only (supplementary Fig. 5). In the groups administrated with ethanol, acetic acid was
significantly elevated, consistent with previous reports which indicate that ethanol is
oxidized to acetaldehyde and subsequently oxidized by the colonic mucosal or bacterial
aldehyde dehydrogenase to acetic acid. This oxidative reaction in vivo showed protective
effect against ethanol-induced damage (Israel et al. 1994). The concentration of BCAAs was
lower in the ethanol-intake groups, especially in the MCFA/ethanol group. In fact,
previously ethanol-fed animals were shown to have more subcutaneous fat and less tissue fat
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such as perinephric fat compared to animals fed without ethanol. Previous studies reported
that BCAAs could be markers for the fat accumulation around organs, even in animals that
exhibit overall low body weight (Newgard et al. 2009). Our results with human samples
provide important baseline information for the SCFA and BCAA concentrations in human
feces, urine and plasma.
4 Concluding remarks
In this study, we describe a rapid and quantitative protocol for the simultaneous analysis of
SCFAs and BCAAs in biological samples using PCF derivatization and GC-MS analysis.
Metabolites were derivatized with 100 µL of PCF in a reaction system of water/PrOH/Py (v/
v/v = 8:3:2) at pH 8.0 prior to a two-step extraction with hexane. Using our novel method,
we analyzed complex biological samples including feces, urine and plasma. Based on its
accuracy, simplicity and robustness, our method is an essential tool in clinical applications
as well as in translational biomedical research.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Abbreviations
SCFAs short-chain fatty acids
BCAAs branched-chain amino acids
PCF propyl chloroformate
GC-MS gas chromatography mass spectrometry
R.S.D.s relative standard deviations
CE capillary electrophoresis
HPLC high performance liquid chromatography
GC gas chromatography





PLS partial least squares regression
LOD limit of detection
MCFAs medium chain fatty acids
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Reaction scheme of two representative compounds, butyric acid and leucine, treated with
PCF derivatization.
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Optimization of the derivatization solvents. The PLS bi-plot shows the correlation between
the peak areas for 12 metabolites and the volumes of three derivatization solvents: water,
propanol (PrOH), and pyridine (Py). The red squares indicate derivatization solvents; the
black triangles indicate detected compounds; and the green squares indicate experimental
methods as numbered in Table 1a.
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Optimization of the derivatization solvents, propanol (PrOH) and pyridine (Py). The bar
plots show total intensities (sum) of normalized intensity of each metabolite, which was
normalized to the average intensity across the six methods. Error bars indicate the standard
error of triplicate samples.
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Table 1
Experimental design for investigating the derivatization efficiency of water, propanol (PrOH), and pyridine
(Py) as derivatization solvents
a. Experimental Design 1 (Orthogonal experiment design)
Expt No. Water (µL) PrOH (µL) Py (µL) Propyl chloroformate (µL)
01 600 100 50 100
02 600 200 100 100
03 600 300 150 100
04 600 400 200 100
05 800 100 100 100
06 800 200 150 100
07 800 300 200 100
08 800 400 50 100
09 1000 100 150 100
10 1000 200 200 100
11 1000 300 50 100
12 1000 400 100 100
13 1200 100 200 100
14 1200 200 50 100
15 1200 300 100 100
16 1200 400 150 100
b. Experimental Design 2
Expt No. Water (µL) PrOH (µL) Py (µL) Propyl chloroformate (µL)
1 800 200 100 100
2 800 200 200 100
3 800 200 300 100
4 800 300 100 100
5 800 300 200 100
6 800 300 300 100
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